Sanyou Bio Partners Baiyunshan Xihe for Radiopharma Innovation
SHANGHAI & GUANGZHOU, China, July 4, 2026 Sanyou Biopharmaceutical Co., Ltd. (Sanyou Bio) and Guangzhou Baiyunshan Xihe Health Pharmaceutical...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SHANGHAI & GUANGZHOU, China, July 4, 2026 Sanyou Biopharmaceutical Co., Ltd. (Sanyou Bio) and Guangzhou Baiyunshan Xihe Health Pharmaceutical...
BERLIN, Germany – June 9, 2026 Pentixapharm Holding AG has achieved a major regulatory milestone after receiving U.S. Food...
